A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy

INTRODUCTION: In proliferative diabetic retinopathy (PDR), vascular endothelial growth factor (VEGF) and connective tissue growth factor (CTGF) may cause blindness by neovascularisation followed by fibrosis of the retina. It has previously been shown that a shift in the balance between levels of CTG...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Van Geest, Rob J, Lesnik-Oberstein, Sarit Y, Tan, H Stevie, Mura, Marco, Goldschmeding, Roel, Van Noorden, Cornelis J F, Klaassen, Ingeborg, Schlingemann, Reinier O
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Group 2012
Pynciau:
Laboratory Science
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3308470/
https://ncbi.nlm.nih.gov/pubmed/22289291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2011-301005
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg